ArticleActa pharmacologica Sinica2021

Catalpol counteracts the pathology in a mouse model of Duchenne muscular dystrophy by inhibiting the TGF-β1/TAK1 signaling pathway.

Deng-Qiu Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.